|
AHCTF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.761700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.607200E-01 |
| Normal-vs-Stage2 |
6.734200E-01 |
| Normal-vs-Stage3 |
4.244700E-03 |
| Normal-vs-Stage4 |
3.232100E-02 |
| Stage1-vs-Stage2 |
8.832200E-01 |
| Stage1-vs-Stage3 |
1.575960E-02 |
| Stage1-vs-Stage4 |
1.367820E-01 |
| Stage2-vs-Stage3 |
1.119840E-01 |
| Stage2-vs-Stage4 |
2.607800E-01 |
| Stage3-vs-Stage4 |
5.497400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.375500E-02 |
| Normal-vs-AfricanAmerican |
1.824430E-02 |
| Normal-vs-Asian |
7.602800E-01 |
| Caucasian-vs-AfricanAmerican |
1.268230E-01 |
| Caucasian-vs-Asian |
4.763400E-01 |
| AfricanAmerican-vs-Asian |
2.145200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.355600E-02 |
| Normal-vs-Female |
2.686400E-01 |
| Male-vs-Female |
2.952000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.923800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.391600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.728500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.255800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.916800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.727400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.209600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.590200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.830550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.018000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.817000E-01 |
| Normal-vs-Grade 2 |
5.176200E-01 |
| Normal-vs-Grade 3 |
9.104600E-03 |
| Normal-vs-Grade 4 |
1.524080E-02 |
| Grade 1-vs-Grade 2 |
1.994210E-01 |
| Grade 1-vs-Grade 3 |
1.897810E-02 |
| Grade 1-vs-Grade 4 |
1.561760E-02 |
| Grade 2-vs-Grade 3 |
2.672100E-02 |
| Grade 2-vs-Grade 4 |
3.977900E-02 |
| Grade 3-vs-Grade 4 |
7.254200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.840800E-01 |
| Normal-vs-ccB subtype |
1.064030E-02 |
| ccA subtype-vs-ccB subtype |
3.169700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.149800E-02 |
| Normal-vs-N1 |
7.557600E-01 |
| N0-vs-N1 |
6.820000E-01 |
|
|
